Systemic Tranexamic Acid for Reduced Postoperative Blood Loss and Less Bleeding Complications in Fleur-de-lis Abdominoplasty and Apronectomy.
Apronectomy
Bleeding complications
Fleur-de-lis abdominoplasty
Postoperative blood loss
Surgical outcome
Tranexamic acid
Journal
Aesthetic plastic surgery
ISSN: 1432-5241
Titre abrégé: Aesthetic Plast Surg
Pays: United States
ID NLM: 7701756
Informations de publication
Date de publication:
28 Mar 2024
28 Mar 2024
Historique:
received:
28
01
2024
accepted:
29
02
2024
medline:
29
3
2024
pubmed:
29
3
2024
entrez:
29
3
2024
Statut:
aheadofprint
Résumé
Strategies minimizing surgical bleeding, including the antifibrinolytic agent tranexamic acid, play a crucial role in clinical practice to optimize overall surgical outcomes. Despite its proven efficacy in various clinical fields, there is a limited understanding regarding the use of tranexamic acid in plastic and aesthetic procedures. This study is the first investigating the effects of systemically administered tranexamic acid on postoperative blood loss and bleeding complications in fleur-de-lis abdominoplasties and apronectomies. Patients who received 1 g tranexamic acid (n = 44) during fleur-de-lis abdominoplasty or apronectomy were retrospectively compared with those who did not (n = 44). In this context, the outcome parameters 24-h and total drain fluid production, drain time, hospital stay, absolute and relative drop in hemoglobin and hematocrit level as well as bleeding complications such as blood transfusion, hematoma puncture and evacuation were evaluated. Tranexamic acid significantly decreased both drainage volume in 24 h (40.5%, p = 0.0046) and total drain fluid production (42.5%, p = 0.0017). Moreover, a shorter drainage time (19.4%, p = 0.0028) and hospital stay (21.4%, p = 0.0009) were observed. The administration of tranexamic acid was also associated with a reduced postoperative decline in hemoglobin and hematocrit levels. Notably, no bleeding complications were observed in patients who received tranexamic acid, while 6 events occurred in patients without (p = 0.0262). Systemic administration of tranexamic acid effectively reduced postoperative blood loss and bleeding complications in fleur-de-lis abdominoplasties and apronectomies. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Sections du résumé
BACKGROUND
BACKGROUND
Strategies minimizing surgical bleeding, including the antifibrinolytic agent tranexamic acid, play a crucial role in clinical practice to optimize overall surgical outcomes. Despite its proven efficacy in various clinical fields, there is a limited understanding regarding the use of tranexamic acid in plastic and aesthetic procedures. This study is the first investigating the effects of systemically administered tranexamic acid on postoperative blood loss and bleeding complications in fleur-de-lis abdominoplasties and apronectomies.
METHODS
METHODS
Patients who received 1 g tranexamic acid (n = 44) during fleur-de-lis abdominoplasty or apronectomy were retrospectively compared with those who did not (n = 44). In this context, the outcome parameters 24-h and total drain fluid production, drain time, hospital stay, absolute and relative drop in hemoglobin and hematocrit level as well as bleeding complications such as blood transfusion, hematoma puncture and evacuation were evaluated.
RESULTS
RESULTS
Tranexamic acid significantly decreased both drainage volume in 24 h (40.5%, p = 0.0046) and total drain fluid production (42.5%, p = 0.0017). Moreover, a shorter drainage time (19.4%, p = 0.0028) and hospital stay (21.4%, p = 0.0009) were observed. The administration of tranexamic acid was also associated with a reduced postoperative decline in hemoglobin and hematocrit levels. Notably, no bleeding complications were observed in patients who received tranexamic acid, while 6 events occurred in patients without (p = 0.0262).
CONCLUSION
CONCLUSIONS
Systemic administration of tranexamic acid effectively reduced postoperative blood loss and bleeding complications in fleur-de-lis abdominoplasties and apronectomies.
LEVEL OF EVIDENCE IV
METHODS
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Identifiants
pubmed: 38548959
doi: 10.1007/s00266-024-03992-5
pii: 10.1007/s00266-024-03992-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.
Références
Shander A (2007) Financial and clinical outcomes associated with surgical bleeding complications. Surgery. https://doi.org/10.1016/j.surg.2007.06.025
doi: 10.1016/j.surg.2007.06.025
pubmed: 18019945
Stokes ME, Ye X, Shah M, Mercaldi K, Reynolds M, Rupnow MF, Hammond J (2011) Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 11:135
doi: 10.1186/1472-6963-11-135
pubmed: 21627788
pmcid: 3126703
Gabay M (2006) Absorbable hemostatic agents. Am J Health Syst Pharm 63:1244–1253
doi: 10.2146/ajhp060003
pubmed: 16790576
Porte RJ, Leebeek FW (2002) Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 62(15):2193–2211
doi: 10.2165/00003495-200262150-00003
pubmed: 12381219
Ker K, Edwards P, Perel P, Shakur H, Roberts I (2012) Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. https://doi.org/10.1136/bmj.e3054
doi: 10.1136/bmj.e3054
pubmed: 22611164
pmcid: 3356857
Zhang Y, Bai Y, Chen M, Zhou Y, Yu X, Zhou H, Chen G (2019) The safety and efficiency of intravenous administration of tranexamic acid in coronary artery bypass grafting (CABG): a meta-analysis of 28 randomized controlled trials. BMC Anesthesiol 19(1):104
doi: 10.1186/s12871-019-0761-3
pubmed: 31195987
pmcid: 6567423
Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, Bini SA, Clarke HD, Schemitsch E, Johnson RL, Memtsoudis SG, Sayeed SA, Sah AP, Della Valle CJ (2018) The efficacy of tranexamic acid in total hip arthroplasty: a network meta-analysis. J Arthroplasty 33(10):3083–3089
doi: 10.1016/j.arth.2018.06.023
pubmed: 30007789
Franchini M, Mengoli C, Cruciani M, Bergamini V, Presti F, Marano G, Pupella S, Vaglio S, Masiello F, Veropalumbo E, Piccinini V, Pati I, Liumbruno GM (2018) Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis. Blood Transfus 16(4):329–337
pubmed: 29757132
pmcid: 6034773
McCormack PL (2012) Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 72(5):585–617
doi: 10.2165/11209070-000000000-00000
pubmed: 22397329
Fachinfo - Service (2023) Prescribing information, Cyklokapron®-Injektionslösung, as of November 2023, https://www.fachinfo.de
Pilbrant A, Schannong M, Vessman J (1981) Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 20(1):65–72
doi: 10.1007/BF00554669
pubmed: 7308275
Murao S, Nakata H, Roberts I, Yamakawa K (2021) Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis. Crit Care 25(1):380
doi: 10.1186/s13054-021-03799-9
pubmed: 34724964
pmcid: 8561958
Franchini M, Mengoli C, Marietta M, Marano G, Vaglio S, Pupella S, Mannucci PM, Liumbruno GM (2018) Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus 16(1):36–43
pubmed: 29337665
pmcid: 5770313
Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network (2017) Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 376(2):136–148
doi: 10.1056/NEJMoa1606424
pubmed: 27774838
Goobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF (2011) Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. Anesthesiology 114(4):862–871
doi: 10.1097/ALN.0b013e318210fd8f
pubmed: 21364458
Kurnik NM, Pflibsen LR, Bristol RE, Singh DJ (2017) Tranexamic acid reduces blood loss in craniosynostosis surgery. J Craniofac Surg 28(5):1325–1329
doi: 10.1097/SCS.0000000000003731
pubmed: 28582303
Murphy GR, Glass GE, Jain A (2016) The efficacy and safety of tranexamic acid in cranio-maxillofacial and plastic surgery. J Craniofac Surg 27(2):374–379
doi: 10.1097/SCS.0000000000002250
pubmed: 26967076
Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M (2010) High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 110(2):350–353
doi: 10.1213/ANE.0b013e3181c92b23
pubmed: 19996135
Sharma V, Katznelson R, Jerath A, Garrido-Olivares L, Carroll J, Rao V, Wasowicz M, Djaiani G (2014) The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11 529 patients. Anaesthesia 69(2):124–130
doi: 10.1111/anae.12516
pubmed: 24588023
Lecker I, Wang DS, Whissell PD, Avramescu S, Mazer CD, Orser BA (2016) Tranexamic acid-associated seizures: causes and treatment. Ann Neurol 79(1):18–26
doi: 10.1002/ana.24558
pubmed: 26580862
Sigaut S, Tremey B, Ouattara A, Couturier R, Taberlet C, Grassin-Delyle S, Dreyfus JF, Schlumberger S, Fischler M (2014) Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 120(3):590–600
doi: 10.1097/ALN.0b013e3182a443e8
pubmed: 23903022
Guo J, Gao X, Ma Y, Lv H, Hu W, Zhang S, Ji H, Wang G, Shi J (2019) Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials. BMC Anesthesiol 19(1):129
doi: 10.1186/s12871-019-0772-0
pubmed: 31307381
pmcid: 6631782
Elena Scarafoni E (2021) A systematic review of tranexamic acid in plastic surgery: what’s new? Plast Reconstr Surg Glob Open. https://doi.org/10.1097/GOX.00000000000
doi: 10.1097/GOX.00000000000
pubmed: 33907653
pmcid: 8062149
Xu JW, Qiang H, Li TL, Wang Y, Wei XX, Li F (2021) Efficacy of topical vs intravenous tranexamic acid in reducing blood loss and promoting wound healing in bone surgery: a systematic review and meta-analysis. World J Clin Cases 9(17):4210–4220
doi: 10.12998/wjcc.v9.i17.4210
pubmed: 34141783
pmcid: 8173404
Zhang P, Liang Y, Chen P, Fang Y, He J, Wang J (2016) Intravenous versus topical tranexamic acid in primary total hip replacement: a meta-analysis. Medicine. https://doi.org/10.1097/MD.0000000000005573
doi: 10.1097/MD.0000000000005573
pubmed: 28033298
pmcid: 5207594
Dai WL, Zhou AG, Zhang H, Zhang J (2018) Most effective regimen of tranexamic acid for reducing bleeding and transfusions in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. J Knee Surg 31(7):654–663
doi: 10.1055/s-0037-1606376
pubmed: 28895645
Wheeler DR, Bucci F, Vaccari S, Di Giuli R, Vinci V, Klinger M (2023) Topical tranexamic acid: risks, benefits and novel complications in aesthetic plastic surgery. Aesthetic Plast Surg. https://doi.org/10.1007/s00266-023-03346-7
doi: 10.1007/s00266-023-03346-7
pubmed: 37069351
Sagiv O, Rosenfeld E, Kalderon E, Barazani TB, Zloto O, Martinowitz U, Ben Simon GJ, Zilinsky I (2018) Subcutaneous tranexamic acid in upper eyelid blepharoplasty: a prospective randomized pilot study. Can J Ophthalmol 53(6):600–604
doi: 10.1016/j.jcjo.2018.01.006
pubmed: 30502984
Kochuba AL, Coombs DM, Kwiecien GJ, Sinclair NR, Zins JE (2021) Prospective study assessing the effect of local infiltration of tranexamic acid on facelift bleeding. Aesthet Surg J 41(4):391–397
doi: 10.1093/asj/sjaa198
pubmed: 32644111
Parmeshwar N, Mehta SR, Piper M (2023) Reviewing the impact of topical and intravenous tranexamic acid use in breast plastic surgery. Ann Plast Surg 91(5):622–628
doi: 10.1097/SAP.0000000000003635
pubmed: 37405863
Ausen K, Fossmark R, Spigset O, Pleym H (2022) Safety and efficacy of local tranexamic acid for the prevention of surgical bleeding in soft-tissue surgery: a review of the literature and recommendations for plastic surgery. Plast Reconstr Surg 149(3):774–787
doi: 10.1097/PRS.0000000000008884
pubmed: 35196701
pmcid: 8860217
Weissler JM, Kuruoglu D, Salinas C, Tran NV, Nguyen MT, Martinez-Jorge J, Bite U, Harless CA, Vijayasekaran A, Sharaf B (2022) Defining the role for topically administered tranexamic acid in panniculectomy surgery. Aesthet Surg J Open Forum. https://doi.org/10.1093/asjof/ojac033
doi: 10.1093/asjof/ojac033
pubmed: 35692487
pmcid: 9174740
Bayter-Marín JE, Hoyos A, Cárdenas-Camarena L, Peña-Pinzón W, Bayter-Torres AF, Díaz-Díaz CA, McCormick-Méndez M, Plata-Rueda EL, Niño-Carreño CS (2023) Effectiveness of tranexamic acid in the postoperative period in body contour surgery: randomized clinical trial. Plast Reconstr Surg Glob Open. https://doi.org/10.1097/GOX.0000000000005403
doi: 10.1097/GOX.0000000000005403
pubmed: 38025645
pmcid: 10653580